Skip to content

Daniel Schneeberger, 10% owner at InMed Pharmaceuticals, bought INM on Sep 14, 2026

Data as of Oct 16

▲ BUY$36.9K28,505 shares at $1.29Daniel Schneeberger 10% ownerINM InMed Pharmaceuticals Inc.
Watch INM
Traded
Sep 14, 2026
Disclosed
Sep 16, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Daniel Schneeberger, 10% owner at InMed Pharmaceuticals, bought INM on Sep 14, 2026TRADEDDISCLOSED
INMSimilar stocks (XLV — its sector index fund), rebased to INM's price on the disclosure day
INM since disclosure
+3.1%
Similar stocks (XLV) since disclosure
+5.3%
XLV — its sector index fund

Change in closing price from Sep 16, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▲ BUYDaniel Schneeberger 10% ownerINM InMed Pharmaceuticals Inc.$10.8Kdisclosed Sep 16 · filed the same day
  2. ▲ BUYADAR1 Capital Management, LLC 10% ownerINM InMed Pharmaceuticals Inc.$10.8Kdisclosed Sep 16 · filed the same day
  3. ▲ BUYADAR1 Capital Management, LLC 10% ownerINM InMed Pharmaceuticals Inc.$70.4Kdisclosed Sep 16 · filed 1 day after the trade
  4. ▲ BUYDaniel Schneeberger 10% ownerINM InMed Pharmaceuticals Inc.$70.4Kdisclosed Sep 16 · filed 1 day after the trade
  5. ▲ BUYADAR1 Capital Management, LLC 10% ownerINM InMed Pharmaceuticals Inc.$36.9Kdisclosed Sep 16 · filed 2 days after the trade

See every trade on INM →